MaxCyte Correlations
MXCT Stock | USD 2.02 0.13 6.05% |
The current 90-days correlation between MaxCyte and Cytek Biosciences is 0.41 (i.e., Very weak diversification). The correlation of MaxCyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
MaxCyte Correlation With Market
Weak diversification
The correlation between MaxCyte and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and DJI in the same portfolio, assuming nothing else is changed.
Moving together with MaxCyte Stock
0.77 | CI | Cigna Corp | PairCorr |
0.81 | EKSO | Ekso Bionics Holdings Earnings Call Next Week | PairCorr |
0.73 | ELMD | Electromed | PairCorr |
0.66 | EMBC | Embecta Corp | PairCorr |
0.81 | ICCM | Icecure Medical | PairCorr |
0.79 | MSPRW | MSP Recovery Symbol Change | PairCorr |
0.71 | MSPRZ | MSP Recovery Symbol Change | PairCorr |
0.66 | MNDR | Mobile health Network | PairCorr |
Moving against MaxCyte Stock
0.88 | OM | Outset Medical | PairCorr |
0.82 | DH | Definitive Healthcare | PairCorr |
0.76 | DXCM | DexCom Inc Earnings Call This Week | PairCorr |
0.71 | VEEV | Veeva Systems Class | PairCorr |
0.67 | LH | Laboratory Earnings Call This Week | PairCorr |
0.54 | VNRX | Volitionrx | PairCorr |
0.48 | MD | Mednax Inc | PairCorr |
0.44 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
0.83 | ENSG | Ensign Group Earnings Call This Week | PairCorr |
0.68 | FIGS | Figs Inc | PairCorr |
0.63 | MDAI | Spectral AI | PairCorr |
0.36 | EHAB | Enhabit | PairCorr |
0.32 | VVOS | Vivos Therapeutics | PairCorr |
0.73 | NAKA | Kindly MD, Symbol Change | PairCorr |
0.71 | MHUA | Meihua International | PairCorr |
0.55 | MODV | ModivCare | PairCorr |
0.44 | NEUE | NeueHealth | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MaxCyte Stock performing well and MaxCyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MaxCyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CTKB | 3.27 | (0.41) | 0.00 | (0.08) | 0.00 | 6.20 | 28.87 | |||
KIDS | 1.83 | (0.10) | (0.02) | 0.06 | 2.24 | 4.06 | 11.10 | |||
ELMD | 2.01 | (0.46) | 0.00 | (0.27) | 0.00 | 3.34 | 17.42 | |||
LUNG | 4.05 | (0.97) | 0.00 | (0.29) | 0.00 | 7.78 | 27.26 | |||
CRBU | 5.41 | 1.36 | 0.24 | 0.77 | 4.79 | 12.02 | 23.18 | |||
GLUE | 3.08 | 0.30 | 0.10 | 0.31 | 3.47 | 7.85 | 21.39 | |||
IPSC | 2.98 | 0.26 | 0.04 | 0.94 | 2.78 | 8.00 | 19.49 | |||
NUVL | 2.03 | 0.14 | 0.06 | 0.26 | 2.44 | 4.52 | 11.99 |
MaxCyte Corporate Management
James Brady | Senior Support | Profile | |
Stark Thompson | Consultant | Profile | |
Jill Mayer | Senior Resources | Profile | |
Cenk Sumen | Chief Officer | Profile | |
Douglas Doerfler | President, Founder | Profile | |
Jay Gelfman | Senior Operations | Profile |